The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Share News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sales growth drives revenue improvement at Collagen Solutions

Tue, 22nd Oct 2019 12:23

(Sharecast News) - Biomaterials and regenerative medicines developer and manufacturer Collagen Solutions updated the market on its trading for the six months ended 30 September on Tuesday, reporting that revenue for the period was expected to rise to £2.23m from £1.95m year-on-year.
The AIM-traded firm said that 14.4% increase was primarily driven by continuing momentum in its newly-established tissue business, adding that new customer acquisition had continued, with four new customer contracts and 10 new customers in the half-year.

In June, it completed a fundraise of £5.96m gross of costs, made up of a strategic investment by Rosen's Diversified of £4.18m, a placing with existing and new investors of £1.25m, and an open offer totalling £0.53m.

The board said the funds were being used to further customer and proprietary product development, expand contract manufacturing activities and capabilities, and for working capital, including the repayment of the Norgine Ventures Bond Facility.

It added that it was continuing to execute on its customer product development milestones, having signed new development customers, which represented additional future contract manufacturing opportunities, once those products are approved and launched.

In addition, the company said it remained "engaged in the process" to address questions from its notified body for the 'ChondroMimetic' CE mark consistent with its previously-stated plans.

"We are pleased to report the third consecutive six-month period of double-digit sales growth demonstrating consistent performance to our expectations by the Collagen Solutions global team," said chief executive officer Jamal Rushdy.

"Our core business remains strong and our initiative to increase capacity is on track to meet the anticipated higher demand for both collagen and tissue products."

As at 1044 BST, shares in Collagen Solutions were down 1.43% at 3.45p.
More News
15 Aug 2018 16:10

UK Shareholder Meetings Calendar - Next 7 Days

Thursday 16 Augustno events scheduledFriday 17 AugustMX 20 21 Natural Focus (re sale

Read more
4 Apr 2018 11:30

Collagen Solutions To Record Widened Annual Loss On Contract Delays

LONDON (Alliance News) - Shares in Collagen Solutions PLC fell Wednesday, after the company warned that it will record a widened loss and lower revenue for the 2018 financial

Read more
28 Mar 2018 11:13

Collagen To Restructure New Zealand Unit, Expects Annual Loss to Widen

LONDON (Alliance News) - Collagen Solutions PLC said Wednesday that it intends to re-structure its New Zealand operations for it to focus its activities a

Read more
14 Feb 2017 12:02

Collagen Solutions announces capital hike

(ShareCast News) - Collagen Solutions announces a placing and open offer to raise up to £8.0m, and a conditional commitment from Norgine Ventures to subscribe for £4.0m in secured private bonds with warrants. AIM-quoted Collagen said the placing and open offer were subject to shareholder approval.

Read more
19 Jan 2017 09:37

Collagen Solutions assembles scientific advisory board

(ShareCast News) - Developer and manufacturer of medical grade collagen components, Collagen Solutions, announced the creation of a new scientific advisory board on Thursday, that will advise the company on opportunities in regenerative medicine. The AIM-traded company said the three appointees are

Read more
13 Jan 2017 12:13

Collagen Solutions awarded another Ph.D. studentship

(ShareCast News) - Developer and manufacturer of medical grade collagen components Collagen Solutions announced on Friday that it has been awarded a third Medical Research Scotland Ph.D. studentship, this time in partnership with Professor Elizabeth Tanner, of the School of Engineering, at the Unive

Read more
19 Dec 2016 08:43

Collagen Solutions pins hopes on ChrondoMimetic as losses widen

(ShareCast News) - Medical grade collagen component developer and manufacturer Collagen Solutions posted its results for the six months to 30 September on Monday, with revenue and other income increasing by 30% to £1.89m. The AIM-traded company's adjusted LBITDA was £0.42m, widening from the £0.79m

Read more
17 Aug 2016 15:04

UK Shareholder Meetings Calendar - Next 7 Days

Read more
12 Jul 2016 16:19

DIRECTOR DEALINGS: Collagen Solutions Chairman Buys Shares

Read more
11 Jul 2016 16:00

LONDON MARKET CLOSE: London Stocks Rise With Theresa May Set For No 10

Read more
11 Jul 2016 15:40

DIRECTOR DEALINGS: Collagen Solutions Chairman Buys More Shares

Read more
11 Jul 2016 15:11

DIRECTOR DEALINGS: Collagen Solutions Chairman Buy 900,000 Shares

Read more
11 Jul 2016 11:11

LONDON MARKET MIDDAY: FTSE 100 Hits High, Pound Jumps On Tory Drama

Read more
11 Jul 2016 11:03

Director dealings: Collagen chairman puts more skin in game

(ShareCast News) - Collagen Solutions chairman David Evans put more skin in the game on Monday as the company revealed annual losses had tightened up thanks to a plumped-up top line. Serial entrepreneur and small company backer Evans took his stake in the company up to 8.6% by snapping up 900,000

Read more
11 Jul 2016 09:21

Collagen Solutions Sees "Positive Start" To Year As Loss Narrows

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.